Physician profile
Elena Bezoff
NPI 1417141532
$12,622.55
in general payments reported to CMS, 2019-2025
43 companies · $1,778 in 2025
The $1,778 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,940 · 2020: $1,467 · 2021: $1,502 · 2022: $1,838 · 2023: $2,389 · 2024: $1,708 · 2025: $1,778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,876.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,394.15 | 2019-2025 | |
| Amgen INC. | $1,024.62 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $1,022.31 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $1,004.47 | 2021-2025 | Verquvo, Capvaxive, Belsomra |
| Astrazeneca Pharmaceuticals LP | $749.51 | 2019-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $651.58 | 2019-2025 | Jardiance, Ofev |
| Genzyme Corporation | $579.43 | 2019-2024 | |
| Amarin Pharma, INC. | $539.93 | 2019-2023 | |
| Cvrx, INC. | $472.73 | 2022-2023 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $469.47 | 2019-2024 | |
| Pfizer INC. | $358.62 | 2019-2025 | |
| Glaxosmithkline, LLC. | $356.60 | 2019-2025 | Nucala |
| Bardy Diagnostics, INC. | $327.15 | 2019-2022 | |
| Heartflow, INC. | $326.53 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $319.38 | 2019-2023 | Evkeeza |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $316.52 | 2019-2025 | Emblem Mri S-Icd, Varithena Administration Pack, Accolade Sr |
| Edwards Lifesciences Corporation | $294.76 | 2019-2025 | Sapien 3 Ultra Resilia |
| Esperion Therapeutics, INC. | $291.39 | 2020-2025 | Nexletol |
| Scpharmaceuticals INC. | $251.43 | 2023-2025 | |
| Irhythm Technologies, INC. | $190.48 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $177.68 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $165.58 | 2021-2022 | |
| Biotronik INC. | $145.40 | 2025 | Amvia Edge |
| Abbott Laboratories | $132.45 | 2019-2021 | |
| Verona Pharma, INC. | $112.00 | 2025 | Ohtuvayre |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $109.47 | 2019-2020 | |
| Medtronic, INC. | $97.06 | 2021-2024 | Corevalve Evolut R, Mycarelink |
| Baxter Healthcare | $88.01 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Lundbeck LLC | $86.91 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $84.77 | 2025 | Opsumit |
| Insmed, INC. | $69.89 | 2020-2022 | |
| Lexicon Pharmaceuticals, INC. | $68.82 | 2023-2024 | Inpefa |
| Medicomp INC | $42.15 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $40.77 | 2019-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $40.28 | 2023 | Arcalyst |
| Arbor Pharmaceuticals, INC. | $37.03 | 2019 | |
| Novo Nordisk INC | $36.84 | 2021-2022 | |
| Gilead Sciences, INC. | $28.31 | 2019 | |
| Astellas Pharma US INC | $27.21 | 2019-2021 | |
| Philips North America LLC | $23.86 | 2024 | (Ck7) Extended Holter |
| Kiniksa Pharmaceuticals International, Plc | $23.11 | 2024 | Arcalyst |
| Mylan Specialty L.P. | $22.00 | 2021 | |
| Alnylam Pharmaceuticals INC. | $21.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elena Bezoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.